About Gujarat Themis Biosyn Ltd
Data last updated: 14 July 2026
Gujarat Themis Biosyn Ltd is a public limited company based in Valsad, Gujarat, India, a subsidiary of Pharmaceutical Business Group(Indipharmaceutical Business Group(India) Limiteda) Limited. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 11 December 1981, the company has been in operation for over 45 years.
Registered with ROC Ahmedabad under CIN L24230GJ1981PLC004878. Listed on BSE: 506879.
Capital: an authorised share capital of ₹25 Cr and a paid-up capital of ₹10.9 Cr. It is led by directors including Dinesh Shantilal Patel and Sachin Dinesh Patel.
Last AGM: 12 September 2025. Financial statements filed for year ended 31 March 2025. Office: 69/C Gidc Industrial Estate Vapi, Valsad, Gujarat, India – 396195.
As per NSE-filed standalone financials for FY 2026, the company reported a revenue of ₹165.82 Cr, a growth of 9.96% compared to the previous year. The net worth stands at ₹287.76 Cr (up 15.85% YoY). Total assets are valued at ₹503.43 Cr (up 67.08% YoY).
The company has a workforce of approximately 354 employees as per the latest available data. It operates as a subsidiary of Pharmaceutical Business Group(Indipharmaceutical Business Group(India) Limiteda) Limited.
The company is associated with 1 brand - Gujarat Themis Biosyn. As per MCA filings, the company has open charges of ₹197.18 Cr and satisfied charges of ₹48.84 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website gtbl.in.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered Address69/C Gidc Industrial Estate Vapi, Valsad, Gujarat, India – 396195
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd has one previous CIN (Corporate Identification Number): U24230GJ1981PLC004878. The current CIN is L24230GJ1981PLC004878, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24230GJ1981PLC004878 | Current |
| U24230GJ1981PLC004878 | Previous |
Associated Brands with Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd operates one associated brand: Gujarat Themis Biosyn. These brands represent Gujarat Themis Biosyn Ltd's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Application development services are provided from Vapi, India. | gtbl.in |
Competitors & Alternatives of Gujarat Themis Biosyn Ltd
Brands and companies operating in the same space as Gujarat Themis Biosyn Ltd include Laurus Labs, Symbiotec, Sterling Pharma Solutions and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Laurus Labs
|
Pharmaceutical and biotechnology company | Hyderabad, India, India | 2005 |
Symbiotec
|
Non-sterile steroid hormone-based APIs and intermediates are manufactured. | Indore, India, India | 2002 |
Sterling Pharma Solutions
|
Contract development, manufacturing, and analytical services for APIs are offered. | Dudley, United Kingdom, United Kingdom | 2016 |
Provepharm Life Solutions
|
APIs and drug products are developed and valorized in pharmaceuticals. | Marseille, France, France | 1998 |
Apicore
|
APIs are manufactured and custom synthesis services are provided. | Somerset, United States, United States | 2004 |
SeQuent
|
APIs are developed and manufactured for therapeutic areas. | Bengaluru, India, India | 2002 |
Jubilant Pharma
|
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | Noida, India, India | 1978 |
Bellen Chemistry
|
APIs and intermediates are researched and manufactured, specializing in heterocycles. | Beijing, China, China | 2007 |
Business Activity of Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Gujarat Themis Biosyn Ltd
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd is audited by GMJ & Co. (ICAI peer reviewed, certificate valid till 2027-03-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| GMJ & Co. (ICAI peer reviewed, certificate valid till 2027-03-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd is currently managed by 7 directors, with 27 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Dinesh Shantilal Patel
Also directs:
Gujarat Themis Biosyn Ltd, Themis Medicare Limited, Dr. Themis Private Limited and 5 more
|
Director | 25 May 1992 | 34 Years 2 Months | Current |
|
Sachin Dinesh Patel
Also directs:
Gujarat Themis Biosyn Ltd, Themis Medicare Limited, Dr. Themis Private Limited and 5 more
|
Managing Director | 25 Oct 2008 | 17 Years 9 Months | Current |
|
Kirandeep Kaur Madan
Also directs:
Gujarat Themis Biosyn Ltd, Sanskar India Foundation
|
Director | 01 May 2021 | 5 Years 3 Months | Current |
|
Rajneesh Kedarnath Anand
Also directs:
Gujarat Themis Biosyn Ltd, Themis Medicare Limited, Richter Themis Medicare (India) Private Limited and 1 more
|
Additional Director | 10 Nov 2025 | 0 Years 9 Months | Current |
| Nihar Ajay Parikh | Director | 01 Aug 2025 | 1 Years 0 Months | Current |
| Hitesh Dharmasinh Gajaria | Director | 14 May 2024 | 2 Years 2 Months | Current |
Financials of Gujarat Themis Biosyn Ltd FY 2026 filings available
Gujarat Themis Biosyn Ltd reported revenue of ₹165.82 Cr (up 9.96% YoY) for FY 2026.
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Revenue from Operations | ₹165.82 Cr | ₹150.8 Cr |
| Other Income | ₹2.43 Cr | ₹2.43 Cr |
| Total Income | ₹168.25 Cr | ₹153.23 Cr |
| Cost of Materials Consumed | ₹30.43 Cr | ₹25.78 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 |
| Changes in Inventories | -₹9.03 Cr | -₹1.27 Cr |
| Employee Benefit Expense | ₹16.51 Cr | ₹12.64 Cr |
| Finance Costs | ₹2.95 Cr | ₹36.4 Lakh |
| Depreciation & Amortisation | ₹12.92 Cr | ₹5.37 Cr |
| Other Expenses | ₹52.38 Cr | ₹44.81 Cr |
| Total Expenses | ₹106.16 Cr | ₹87.69 Cr |
| Profit Before Exceptional Items & Tax | ₹62.09 Cr | ₹65.54 Cr |
| Exceptional Items | ₹0 | ₹0 |
| Profit Before Tax | ₹62.09 Cr | ₹65.54 Cr |
| Total Tax Expense | ₹15.41 Cr | ₹16.77 Cr |
| Net Profit | ₹46.68 Cr | ₹48.77 Cr |
| Other Comprehensive Income | ₹50,000 | ₹5.1 Lakh |
| Total Comprehensive Income | ₹46.69 Cr | ₹48.82 Cr |
| EBITDA (computed) | ₹77.96 Cr | ₹71.28 Cr |
| Basic EPS | ₹0.00 | ₹4.48 |
| Diluted EPS | ₹0.00 | ₹4.48 |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Total Assets | ₹503.43 Cr | ₹301.31 Cr |
| Non-current Assets | ₹414.64 Cr | ₹249.34 Cr |
| Current Assets | ₹88.78 Cr | ₹51.97 Cr |
| Property, Plant & Equipment | ₹286.92 Cr | ₹40.58 Cr |
| Inventories | ₹15.42 Cr | ₹5.05 Cr |
| Trade Receivables | ₹60.92 Cr | ₹31.24 Cr |
| Cash & Equivalents | ₹3.12 Cr | ₹11.69 Cr |
| Equity (Net Worth) | ₹287.76 Cr | ₹248.38 Cr |
| Equity Share Capital | ₹10.9 Cr | ₹10.9 Cr |
| Borrowings (Non-current) | ₹128.06 Cr | ₹29.64 Cr |
| Borrowings (Current) | ₹31.8 Cr | ₹25.39 Lakh |
| Total Debt (computed) | ₹159.87 Cr | ₹29.89 Cr |
| Current Liabilities | ₹79.16 Cr | ₹20.56 Cr |
| Total Liabilities | ₹215.67 Cr | ₹52.93 Cr |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Operating Cash Flow | ₹48.78 Cr | ₹91.03 Cr |
| Investing Cash Flow | -₹172.28 Cr | -₹111.82 Cr |
| Financing Cash Flow | ₹114.93 Cr | ₹26.01 Cr |
| Capital Expenditure | ₹172.53 Cr | ₹116.15 Cr |
| Free Cash Flow (computed) | -₹123.76 Cr | -₹25.12 Cr |
| Dividends Paid | ₹7.3 Cr | ₹1.82 Cr |
| Net Change in Cash | -₹8.57 Cr | ₹5.22 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 |
|---|---|---|---|---|---|
| Revenue from Operations | ₹44.23 Cr | ₹43.37 Cr | ₹42.35 Cr | ₹35.87 Cr | ₹37.74 Cr |
| Other Income | ₹92.11 Lakh | ₹41.62 Lakh | ₹81.63 Lakh | ₹27.44 Lakh | ₹1.35 Cr |
| Total Income | ₹45.15 Cr | ₹43.78 Cr | ₹43.17 Cr | ₹36.15 Cr | ₹39.08 Cr |
| Cost of Materials Consumed | ₹10.05 Cr | ₹6.62 Cr | ₹6.92 Cr | ₹6.83 Cr | ₹6.85 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | -₹6.5 Cr | -₹79.85 Lakh | -₹1.53 Cr | -₹19.88 Lakh | -₹62.58 Lakh |
| Employee Benefit Expense | ₹3.79 Cr | ₹4.76 Cr | ₹4.85 Cr | ₹3.11 Cr | ₹3.14 Cr |
| Finance Costs | ₹1.91 Cr | ₹96.04 Lakh | ₹4.04 Lakh | ₹4.21 Lakh | ₹7.14 Lakh |
| Depreciation & Amortisation | ₹4.04 Cr | ₹3.89 Cr | ₹2.96 Cr | ₹2.03 Cr | ₹1.23 Cr |
| Other Expenses | ₹17.52 Cr | ₹11.48 Cr | ₹11.16 Cr | ₹12.21 Cr | ₹12.33 Cr |
| Total Expenses | ₹30.82 Cr | ₹26.91 Cr | ₹24.4 Cr | ₹24.03 Cr | ₹23 Cr |
| Profit Before Exceptional Items & Tax | ₹14.34 Cr | ₹16.87 Cr | ₹18.76 Cr | ₹12.12 Cr | ₹16.09 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹14.34 Cr | ₹16.87 Cr | ₹18.76 Cr | ₹12.12 Cr | ₹16.09 Cr |
| Total Tax Expense | ₹3.45 Cr | ₹4.41 Cr | ₹4.5 Cr | ₹3.06 Cr | ₹4.09 Cr |
| Net Profit | ₹10.89 Cr | ₹12.46 Cr | ₹14.27 Cr | ₹9.06 Cr | ₹12 Cr |
| Other Comprehensive Income | ₹42,000 | ₹2.46 Lakh | ₹1.27 Lakh | ₹1.27 Lakh | ₹5.81 Lakh |
| Total Comprehensive Income | ₹10.9 Cr | ₹12.49 Cr | ₹14.28 Cr | ₹9.07 Cr | ₹12.06 Cr |
| EBITDA (computed) | ₹20.28 Cr | ₹21.72 Cr | ₹21.76 Cr | ₹14.2 Cr | ₹17.39 Cr |
| Basic EPS | ₹0.00 | ₹1.14 | ₹1.31 | ₹0.83 | ₹1.10 |
| Diluted EPS | ₹0.00 | ₹1.14 | ₹1.31 | ₹0.83 | ₹1.10 |
Shareholding Pattern of Gujarat Themis Biosyn Ltd
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 70.86%, foreign institutional investors hold 1.80%, domestic institutional investors hold 1.18%, retail and other public shareholders hold 26.16% of Gujarat Themis Biosyn Ltd. The company had 26,886 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Feb 2025 | |
|---|---|---|---|---|---|---|
| Promoters | 70.86% | 70.86% | 70.86% | 70.86% | 70.86% | 70.86% |
| Public | 29.14% | 29.14% | 29.14% | 29.14% | 29.14% | 29.14% |
| Mar 2026 | Mar 2025 | |
|---|---|---|
| Promoters | 70.86% | 70.86% |
| Public | 29.14% | 29.14% |
| Promoter change (YoY, %pts) | +0.00 | - |
Board & Governance of Gujarat Themis Biosyn Ltd
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Gujarat Themis Biosyn Ltd has 7 directors - 4 independent and 1 executive. The board is chaired by Dinesh Shantilal Patel.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Dinesh Shantilal Patel | Non-Executive - Non Independent Director · Chairperson | 1992-05-25 | 2 |
| Sachin Dinesh Patel | Executive Director · MD | 2025-07-01 | 2 |
| Kirandeep Madan | Non-Executive - Independent Director | 2021-05-01 | 1 |
| Hitesh Dharmasinh Gajaria | Non-Executive - Independent Director | 2024-05-14 | 1 |
| K.G. Anathakrishnan | Non-Executive - Independent Director | 2024-07-26 | 3 |
| Nihar Ajay Parikh | Non-Executive - Independent Director | 2025-08-01 | 1 |
| Rajneesh Kedarnath Anand | Non-Executive - Non Independent Director | 2025-11-10 | 2 |
| Committee | Members |
|---|---|
| Audit Committee | Hitesh Dharmasinh Gajaria (Chairperson), Sachin Dinesh Patel, K.G. Anathakrishnan, Nihar Ajay Parikh |
| Nomination and remuneration committee | Hitesh Dharmasinh Gajaria (Chairperson), Dinesh Shantilal Patel, Nihar Ajay Parikh |
| Stakeholders Relationship Committee | Dinesh Shantilal Patel (Chairperson), Sachin Dinesh Patel, Nihar Ajay Parikh, Rajneesh Kedarnath Anand |
| Risk Management Committee | Sachin Dinesh Patel (Chairperson), Rajneesh Kedarnath Anand, Nihar Ajay Parikh |
| Corporate Social Responsibility Committee | Dinesh Shantilal Patel (Chairperson), Sachin Dinesh Patel, Nihar Ajay Parikh, Rajneesh Kedarnath Anand |
Charges & Borrowings of Gujarat Themis Biosyn Ltd
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Feb 2026 | Others | ₹65 Cr | Open |
| 29 Sep 2025 | Others | ₹50 Cr | Open |
| 22 Nov 2024 | Others | ₹80 Cr | Open |
| 17 Jun 2024 | Others | ₹1.43 Cr | Open |
| 19 Oct 2000 | The Vysya Bank Ltd. | ₹75 Lakh | Open |
Total charge records: 17 View all charges
Employees and EPFO Compliance at Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd has a workforce of 354 employees as of Apr 09, 2024.
Employee and EPFO history for Gujarat Themis Biosyn Ltd
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Gujarat Themis Biosyn Ltd
GST registrations and filing compliance for Gujarat Themis Biosyn Ltd
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Gujarat Themis Biosyn Ltd
Credit ratings, litigation, and regulatory alerts for Gujarat Themis Biosyn Ltd
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Gujarat Themis Biosyn Ltd
MSME payment history for Gujarat Themis Biosyn Ltd
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Gujarat Themis Biosyn Ltd
Corporate group structure for Gujarat Themis Biosyn Ltd
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Gujarat Themis Biosyn Ltd
MCA filings and documents for Gujarat Themis Biosyn Ltd
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Gujarat Themis Biosyn Ltd
Recent News on Gujarat Themis Biosyn Ltd
Frequently Asked Questions about Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd is an active public limited company in the pharma sector based in Valsad, Gujarat, India. It was incorporated on 11 December 1981 (45+ years old) and is registered under CIN L24230GJ1981PLC004878. Listed on BSE: 506879. The company has 354 employees.
Gujarat Themis Biosyn Ltd reported revenue of ₹165.82 Cr for FY 2026 (up 9.96% YoY) based on standalone NSE filings.
The current directors of Gujarat Themis Biosyn Ltd are:
- Dinesh Shantilal Patel - Director
- Sachin Dinesh Patel - Managing Director
- Kirandeep Kaur Madan - Director
- Rajneesh Kedarnath Anand - Additional Director
- Nihar Ajay Parikh - Director
- Hitesh Dharmasinh Gajaria - Director
- Kumarapuram Gopalakrishnan Ananthakrishnan - Director
The primary industry of Gujarat Themis Biosyn Ltd is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Yes. Gujarat Themis Biosyn Ltd is listed on BSE with code 506879.
Gujarat Themis Biosyn Ltd can be reached at the registered office: 69C Gidc Industrial Estate Vapi, Valsad, Gujarat, India – 396195, or through the website gtbl.in.